Heidari F, Kazemi-Sefat N, Feizollahi P, Gerdabi S, Pourfathollah A, Ebtekar M
Mol Biol Rep. 2025; 52(1):313.
PMID: 40085277
DOI: 10.1007/s11033-025-10396-4.
Song J, Kim S, Kim Y, Park S, Jeong S, Park S
Sci Rep. 2025; 15(1):7949.
PMID: 40055388
PMC: 11889116.
DOI: 10.1038/s41598-025-90996-z.
Messeha S, Fidudusola F, Gendy S, Latinwo L, Odewumi C, Soliman K
Nutrients. 2025; 17(2).
PMID: 39861398
PMC: 11767473.
DOI: 10.3390/nu17020267.
Ayoub M, Susin S, Bauvois B
Cancers (Basel). 2025; 17(1.
PMID: 39796700
PMC: 11719013.
DOI: 10.3390/cancers17010072.
Naji N, Sathish M, Karantanos T
Cancers (Basel). 2024; 16(23).
PMID: 39682161
PMC: 11640130.
DOI: 10.3390/cancers16233974.
Furosemide‑induced eradication of myeloblasts via the inhibition of tumor necrosis factor‑α expression in a patient with acute biphenotypic leukemia: A case report.
Chang Y, Chao W, Lai Y, Fan F
Oncol Lett. 2024; 28(6):578.
PMID: 39397800
PMC: 11467830.
DOI: 10.3892/ol.2024.14711.
A New Histology-Based Prognostic Index for Aggressive T-Cell lymphoma: Preliminary Results of the "TCL Urayasu Classification".
Nitta H, Takizawa H, Mitsumori T, Iizuka-Honma H, Ochiai T, Furuya C
J Clin Med. 2024; 13(13).
PMID: 38999437
PMC: 11242040.
DOI: 10.3390/jcm13133870.
Systems Biology for Drug Target Discovery in Acute Myeloid Leukemia.
Novikova S, Tolstova T, Kurbatov L, Farafonova T, Tikhonova O, Soloveva N
Int J Mol Sci. 2024; 25(9).
PMID: 38731835
PMC: 11083274.
DOI: 10.3390/ijms25094618.
Malignant progression of preleukemic disorders.
Hall T, Gurbuxani S, Crispino J
Blood. 2024; 143(22):2245-2255.
PMID: 38498034
PMC: 11181356.
DOI: 10.1182/blood.2023020817.
The Expression and Activation of the NF-κB Pathway Correlate with Methotrexate Resistance and Cell Proliferation in Acute Lymphoblastic Leukemia.
Canevarolo R, Cury N, Yunes J
Genes (Basel). 2023; 14(10).
PMID: 37895229
PMC: 10606671.
DOI: 10.3390/genes14101880.
Methyl-Thiol-Bridged Oxadiazole and Triazole Heterocycles as Inhibitors of NF-κB in Chronic Myelogenous Leukemia Cells.
Basappa B, Jung Y, Ravish A, Xi Z, Swamynayaka A, Madegowda M
Biomedicines. 2023; 11(6).
PMID: 37371757
PMC: 10296415.
DOI: 10.3390/biomedicines11061662.
Molecular Evaluation of the Impact of Polymorphic Variants in Apoptotic () and Proinflammatory Cytokine () Genes on the Susceptibility and Progression of Myeloproliferative Neoplasms: A Case-Control Biomarker Study.
Moawadh M, Mir R, Tayeb F, Asim O, Ullah M
Curr Issues Mol Biol. 2023; 45(5):3933-3952.
PMID: 37232720
PMC: 10217376.
DOI: 10.3390/cimb45050251.
Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro.
Navarrete-Meneses M, Salas-Labadia C, Juarez-Velazquez M, Moreno-Lorenzana D, Gomez-Chavez F, Olaya-Vargas A
Int J Mol Sci. 2023; 24(7).
PMID: 37047231
PMC: 10094043.
DOI: 10.3390/ijms24076259.
Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia.
Wen J, Xu F, Zhou Q, Shi L, Liu Y, Yue J
BMC Cancer. 2023; 23(1):27.
PMID: 36611025
PMC: 9824944.
DOI: 10.1186/s12885-022-10499-2.
Circadian Rhythm Dysregulation and Leukemia Development: The Role of Clock Genes as Promising Biomarkers.
Sanford A, da Cunha L, Machado C, DE Pinho Pessoa F, Silva A, Ribeiro R
Int J Mol Sci. 2022; 23(15).
PMID: 35897788
PMC: 9332415.
DOI: 10.3390/ijms23158212.
5-Demethylnobiletin Inhibits Cell Proliferation, Downregulates ID1 Expression, Modulates the NF-κB/TNF-α Pathway and Exerts Antileukemic Effects in AML Cells.
Chen P, Wang C, Tsao E, Chen Y, Wu M, Ho C
Int J Mol Sci. 2022; 23(13).
PMID: 35806401
PMC: 9266321.
DOI: 10.3390/ijms23137392.
Serum Tumor Necrosis Factor-Alpha Levels in Acute Leukemia and Its Prognostic Significance.
Verma S, Singh A, Yadav G, Kushwaha R, Ali W, Verma S
Cureus. 2022; 14(5):e24835.
PMID: 35547942
PMC: 9090230.
DOI: 10.7759/cureus.24835.
Effects of SIDT2 on the miR-25/NOX4/HuR axis and SIRT3 mRNA stability lead to ROS-mediated TNF-α expression in hydroquinone-treated leukemia cells.
Wang L, Lee Y, Chiou J, Chen Y, Chang L
Cell Biol Toxicol. 2022; 39(5):2207-2225.
PMID: 35302183
DOI: 10.1007/s10565-022-09705-5.
A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia.
Bolandi S, Pakjoo M, Beigi P, Kiani M, Allahgholipour A, Goudarzi N
Cells. 2021; 10(11).
PMID: 34831055
PMC: 8616250.
DOI: 10.3390/cells10112833.
Emerging Bone Marrow Microenvironment-Driven Mechanisms of Drug Resistance in Acute Myeloid Leukemia: Tangle or Chance?.
Ciciarello M, Corradi G, Forte D, Cavo M, Curti A
Cancers (Basel). 2021; 13(21).
PMID: 34771483
PMC: 8582363.
DOI: 10.3390/cancers13215319.